Ryuji Uozumi (R Uozumi)

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 16

Top Topics

Rheumatoid Arthritis

Interstitial Lung Disease

Disease Activity

Top Venues

Journal of hepato-biliary-pancreatic sciences

Arthritis & rheumatology (Hoboken, N.J.)

This page only lists publications with an associated author ORCID identifier.

Publications

Siyuan Yao, Shintaro Yagi, Masaaki Hirata, Yosuke Miyachi, Eri Ogawa, Ryuji Uozumi, Takuya Sugimoto, Takashi Asahara, Shinji Uemoto, Etsuro Hatano
Chronological changes in the gut microbiota and intestinal environment in recipients and donors of living donor liver transplantation. Journal of hepato-biliary-pancreatic sciences (2022)
Naomi Akiyama, Ryuji Uozumi, Tomoya Akiyama, Keisuke Koeda, Takeru Shiroiwa, Kuniaki Ogasawara
Choking injuries: Associated factors and error-producing conditions among acute hospital patients in Japan. PloS one 17 (4) (2022)
Tomohiro Oiwa, Mami Ishibashi, Toshiaki Okuno, Mai Ohba, Yuichiro Endo, Ryuji Uozumi, Feras M Ghazawi, Kazue Yoshida, Hironori Niizeki, Takehiko Yokomizo, Takashi Nomura, Kenji Kabashima
Eicosanoid profiling in patients with complete form of pachydermoperiostosis carrying SLCO2A1 mutations. The Journal of dermatology 48 (9) (2021)
Takuma Watanabe, Keita Asai, Shizuko Fukuhara, Ryuji Uozumi, Kazuhisa Bessho
Effectiveness of surgery and hyperbaric oxygen for antiresorptive agent-related osteonecrosis of the jaw: A subgroup analysis by disease stage. PloS one 16 (1) (2021)
Takayuki Kondo, Haruhiko Banno, Taro Okunomiya, Yoko Amino, Kayoko Endo, Akiyoshi Nakakura, Ryuji Uozumi, Akemi Kinoshita, Harue Tada, Satoshi Morita, Hidehiro Ishikawa, Akihiro Shindo, Ken Yasuda, Yosuke Taruno, Takakuni Maki, Takashi Suehiro, Kohji Mori, Manabu Ikeda, Koji Fujita, Yuishin Izumi, Kazutomi Kanemaru, Kenji Ishii, Kazue Shigenobu, Yumiko Kutoku, Yoshihide Sunada, Shinobu Kawakatsu, Shunji Shiota, Toshifumi Watanabe, Osamu Uchikawa, Ryosuke Takahashi, Hidekazu Tomimoto, Haruhisa Inoue
Repurposing bromocriptine for Aβ metabolism in Alzheimer's disease (REBRAnD) study: randomised placebo-controlled double-blind comparative trial and open-label extension trial to investigate the safety and efficacy of bromocriptine in Alzheimer's disease with presenilin 1 (PSEN1) mutations. BMJ open 11 (6) (2021)
Shigeki Hirabayashi, Ryuji Uozumi, Tadakazu Kondo, Yasuyuki Arai, Takahito Kawata, Naoyuki Uchida, Atsushi Marumo, Kazuhiro Ikegame, Takahiro Fukuda, Tetsuya Eto, Masatsugu Tanaka, Atsushi Wake, Junya Kanda, Takafumi Kimura, Ken Tabuchi, Tatsuo Ichinohe, Yoshiko Atsuta, Masamitsu Yanada, Shingo Yano
Personalized prediction of overall survival in patients with AML in non-complete remission undergoing allo-HCT. Cancer medicine 10 (13) (2021)
Chiaki Hosoda, Takashi Ishiguro, Ryuji Uozumi, Miyuki Ueda, Naomi Takata, Noboru Takayanagi
Characteristics of pulmonary cryptococcosis in patients with rheumatoid arthritis. BMJ open respiratory research 8 (1) (2021)
A Murashima-Suginami, H Kiso, Yoshihito Tokita, Emiko Mihara, Y Nambu, Ryuji Uozumi, Yasuhiko Tabata, K Bessho, Junichi Takagi, M Sugai, Katsu Takahashi
Anti-USAG-1 therapy for tooth regeneration through enhanced BMP signaling. Science advances 7 (7) (2021)
Satoshi Funada, Norio Watanabe, Takayuki Goto, Hiromitsu Negoro, Shusuke Akamatsu, Ryuji Uozumi, Sanae Kishimoto, Kentaro Ichioka, Takehiko Segawa, Toshiaki A Furawaka, Osamu Ogawa
Clinical feasibility and acceptability of adding cognitive behavioral therapy to pharmacotherapy for drug-resistant overactive bladder in women: A single-arm pilot study. Lower urinary tract symptoms 13 (1) (2020)
Hideaki Tsuji, Ran Nakashima, Yuji Hosono, Yoshitaka Imura, Masato Yagita, Hajime Yoshifuji, Shintaro Hirata, Takaki Nojima, Eiji Sugiyama, Kazuhiro Hatta, Yoshio Taguchi, Masaki Katayama, Kiminobu Tanizawa, Tomohiro Handa, Ryuji Uozumi, Shuji Akizuki, Kosaku Murakami, Motomu Hashimoto, Masao Tanaka, Koichiro Ohmura, Tsuneyo Mimori
Multicenter Prospective Study of the Efficacy and Safety of Combined Immunosuppressive Therapy With High-Dose Glucocorticoid, Tacrolimus, and Cyclophosphamide in Interstitial Lung Diseases Accompanied by Anti-Melanoma Differentiation-Associated Gene 5-Positive Dermatomyositis. Arthritis & rheumatology (Hoboken, N.J.) 72 (3) (2020)
Siyuan Yao, Toshimi Kaido, Ryuji Uozumi, Masaaki Hirata, Sena Iwamura, Yosuke Miyachi, Mahmoud Macshut, Mohamed Sharshar, Shintaro Yagi, Shinji Uemoto
Diagnostic potential of presepsin in bacterial infection following hepato-biliary-pancreatic surgery: A prospective observational study. Journal of hepato-biliary-pancreatic sciences 27 (10) (2020)
Keiko Imamura, Yuishin Izumi, Haruhiko Banno, Ryuji Uozumi, Satoshi Morita, Naohiro Egawa, Takashi Ayaki, Makiko Nagai, Kazutoshi Nishiyama, Yasuhiro Watanabe, Ritsuko Hanajima, Ryosuke Oki, Koji Fujita, Naoto Takahashi, Takafumi Ikeda, Akira Shimizu, Akiko Morinaga, Tomoko Hirohashi, Yosuke Fujii, Ryosuke Takahashi, Haruhisa Inoue
Induced pluripotent stem cell-based Drug Repurposing for Amyotrophic lateral sclerosis Medicine (iDReAM) study: protocol for a phase I dose escalation study of bosutinib for amyotrophic lateral sclerosis patients. BMJ open 9 (12) (2019)
Ryuji Uozumi, Shinjo Yada, Atsushi Kawaguchi
Patient recruitment strategies for adaptive enrichment designs with time-to-event endpoints. BMC medical research methodology 19 (1) (2019)
H Kiso, K Takahashi, S Mishima, A Murashima-Suginami, A Kakeno, T Yamazaki, K Asai, Y Tokita, Ryuji Uozumi, M Sugai, Hidemitsu Harada, B Huang, M MacDougall, K Bessho
Third Dentition Is the Main Cause of Premolar Supernumerary Tooth Formation. Journal of dental research 98 (9) (2019)
Tamami Yoshida, Motomu Hashimoto, Rie Kawahara, Hiroko Yamamoto, Masao Tanaka, Hiromu Ito, Izuru Masuda, Kiminori Hosoda, Wataru Yamamoto, Ryuji Uozumi, Satoshi Morita, Yasutomo Fujii, Tsuneyo Mimori, Kazuko Nin
Non-obese visceral adiposity is associated with the risk of atherosclerosis in Japanese patients with rheumatoid arthritis: a cross-sectional study. Rheumatology international 38 (9) (2018)
Ryuji Uozumi, Chikuma Hamada
Adaptive Seamless Design for Establishing Pharmacokinetic and Efficacy Equivalence in Developing Biosimilars. Therapeutic innovation & regulatory science 51 (6) (2017)